Physician profile
Kathy I Wang
NPI 1053499608
$10,988.12
in general payments reported to CMS, 2019-2025
36 companies · $2,727 in 2025
The $2,727 reported for 2025 was more than what 83% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $502 · 2021: $771 · 2022: $703 · 2023: $1,948 · 2024: $2,763 · 2025: $2,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,808 · Food and Beverage: $3,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,807.75 |
| Food and Beverage | $3,630.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,664.31 | 2019-2025 | Intracept, General - Therapies, General - Pain Management |
| Nevro Corp. | $1,893.27 | 2019-2024 | Senza |
| Abbott Laboratories | $900.02 | 2019-2020 | |
| Relievant Medsystems, INC. | $690.27 | 2023 | Intracept |
| Stryker Corporation | $666.42 | 2025 | Optablate, Mild Device Kit |
| Globus Medical, INC. | $632.97 | 2025 | Senza |
| Mml US, INC. | $585.73 | 2023 | Reactiv8 |
| Nalu Medical, INC. | $266.33 | 2024 | Nalu Neurostimulation System |
| Teva Pharmaceuticals USA, INC. | $198.97 | 2019-2022 | |
| Medtronic, INC. | $193.87 | 2022-2024 | Intellis Adaptivestim |
| Abbvie INC. | $190.73 | 2022-2025 | Venclexta, Botox |
| Collegium Pharmaceutical, INC. | $168.51 | 2019-2023 | Xtampza, Belbuca |
| Kerecis Limited | $102.29 | 2019 | |
| Pfizer INC. | $101.47 | 2019-2023 | |
| Spr Therapeutics, INC | $95.55 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $88.70 | 2025 | Lif |
| Si-Bone, INC. | $85.08 | 2024 | |
| Daiichi Sankyo INC. | $84.08 | 2019 | |
| Amgen INC. | $38.83 | 2020-2023 | |
| Biodelivery Sciences International, INC. | $37.40 | 2021 | |
| Stratus Medical, LLC | $32.87 | 2022 | |
| Painteq LLC | $31.51 | 2024 | Painteq |
| Lilly USA, LLC | $29.41 | 2019 | |
| Kite Pharma, INC. | $23.73 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.40 | 2019 | |
| Arteriocyte Medical Systems, INC. | $17.11 | 2022 | |
| Radius Health, INC. | $16.78 | 2020 | |
| Merck Sharp & Dohme LLC | $16.37 | 2023 | Bridion |
| Novartis Pharmaceuticals Corporation | $16.22 | 2019 | |
| Baudax Bio INC. | $16.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.21 | 2022 | |
| Stimwave Technologies Incorporated | $14.75 | 2019 | |
| Allergan, INC. | $13.58 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.37 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.33 | 2021 | |
| Medtronic USA, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.